Cost effectiveness of alendronate (fosamax) for the treatment of osteoporosis and prevention of fractures.
Johnell O; Jönsson B; Jönsson L; Black D; Pharmacoeconomics, 2003, vol. 21, issue 5, p 305, ISSN 11707690. ISBN 11707690.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef